Key result
CHA2DS2-VASc score reliably identifies low-risk AF patients to guide thromboprophylaxis.
Why the study?
Stroke risk stratification tools aim to reduce ischemic stroke and limit unnecessary thromboprophylaxis in patients with AF, including those with valvular heart disease.
The CHA2DS2-VASc score remains the cornerstone for stroke risk stratification in atrial fibrillation, guiding the appropriate use of oral anticoagulants to prevent thromboembolism.
Supports CHA2DS2-VASc for AF stroke risk stratification in practice; leaves open need for prospective comparisons with emerging scores.
Atrial Fibrillation (AF) has become a major global health concern being the most common sustained arrhythmia in clinical practice. Risk factors for AF include congestive heart failure, hypertension, increasing age and diabetes. Many of these factors also increase the risk for thromboembolism and ischemic stroke in AF patients. Great efforts have been made from the latter part of the 20th century towards developing an ideal stroke risk stratification tool in AF with the aim of reducing the incidence of stroke in AF patients and the limiting unnecessary use of thromboprophylaxis. The thromboembolic risks posed by AF with valvular heart disease are an important subgroup that contributes to a significant proportion of stroke in AF patients globally. We review the evolution of stroke risk stratification and summarize the guidelines for stroke prevention in non-valvular AF as well as AF with valvular heart disease, and the most recent recommendations on stroke prevention in AF patients.Abbreviations: AF: Atrial Fibrillation; ACS: Acute Coronary Syndrome; CAD: Coronary Artery Disease; CCF: Congestive Cardiac Failure; DM: Diabetes Mellitus; EHRA: Evaluated Heartvalves, Rheumatic or Artificial; ICH: Intracranial Hemorrhage; NOACs: Novel Oral Anticoagulants; OAC: Oral Anticoagulants; PAD: Peripheral Arterial Disease ; TIA: Transient Ischemic Attack; VHD: Valvular Heart Disease.
No takes yet. Share an insight, caveat, or question.
Oladiran et al. (2019) conducted a review in Atrial Fibrillation. The CHA2DS2-VASc scoring system remains the most widely used tool for stroke risk stratification in atrial fibrillation, reliably identifying low-risk patients to guide appropriate thromboprophylaxis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: